What are pharma companies awaiting from the start-ups they would like to interact with?
Learn from success stories of pharma-biotech collaborations through successful deals they made. What were the hurdles to these deals? What are the keys to carry a good partnership? What are the factors of success and how to handle them? When is it the best time to go meet with pharma for a biotech start-up?
Learn from figures and statistics: how many people get a deal at the end? How to picture an innovation in the best possible way to make a deal? How interactions between early-stage projects and pharma help anticipate pitfalls at the very early development stages? How innovative products have proven to come out of these deals?
This session advocates that a problem shared is a problem solved.